Latest Vaccinogen Inc. Stories
Entrepreneur and executive leader brings more than 35 years of financial and accounting expertise to company FREDERICK, Md., Feb.
Established business leader brings more than 40 years of pharmaceutical operations and commercialization expertise to the company FREDERICK, Md., Feb.
Proceeds will Fund ACTIVE: the Phase IIIb OncoVAX® Trial and Company Expansion FREDERICK, Md., Jan.
Industry veteran brings nearly 20 years of pharmaceutical development and licensing experience to the company FREDERICK, Md., Jan.
Initial Closing is for $10 Million FREDERICK, Md., Aug.
FREDERICK, Md., Nov. 9, 2010 /PRNewswire/ -- Vaccinogen BV, a wholly-owned subsidiary of Vaccinogen, Inc. has been granted a Hospital Exemption by the Dutch Ministry of Health, Welfare and Sport for its colon cancer vaccine, OncoVAXÂ®.
FREDERICK, Md., Sept. 30 /PRNewswire/ -- Vaccinogen, Inc. has appointed veteran biotechnology executive Michael L.
- A person or thing gazed at with wonder or curiosity, especially of a scornful kind.